Hyperbolic Tapering Tips: Enablers and Barriers,
with Mark Horowitz, MBBS PhD
Monday, July 28, 2025
10-11 a.m PST | 1-2 p.m. EST | 5-6 p.m. GMT
Register today! Registration closed noon PST July 26, 2025
Psychiatric researcher and clinician Mark Horowitz, MBBS, PhD, originator of the Horowitz-Taylor method for hyperbolic tapering of psychotropics and lead author of the 2024 Maudsley Deprescribing Guidelines for Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs, will present an overview of the facilitators to implementing careful tapering in clinical practice as well as some barriers. He will also touch upon a few tips and tricks, such as micro-tapering, the art of updosing and reinstatement, and managing protracted withdrawal.
A short question and answer period will follow Mark’s presentation. A video of the webinar will be available for those who register but find they cannot attend. Please register for this webinar today.
The Maudsley Deprescribing Guidelines have been endorsed by the UK Royal Pharmaceutical Society and the Royal Australian College of General Practitioners. With this book as a basis, Mark, who is a Clinical Research Fellow in Psychiatry in the NHS, has been commissioned by Health Education England to prepare a teaching module for NHS clinicians on how to safely stop antidepressants.
Mark holds a PhD from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London in the neurobiology of depression and antidepressant action. He is Visiting Lecturer in Psychopharmacology at King’s College London and an Associate Editor of the journal Therapeutic Advances in Psychopharmacology.
He co-authored the Royal College of Psychiatrists’ guidance on ‘Stopping Antidepressants’ and his work informed the recent NICE guidelines on safe tapering of psychiatric medications, including antidepressants, benzodiazepines and z-drugs. He has worked with the NHS to develop national guidance for safe deprescribing for clinicians.
Mark has written many papers about safe approaches to tapering psychiatric medications, including publications in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin.
His own experience of difficulty of coming off psychiatric medications has informed his interest in rational psychopharmacology and deprescribing psychiatric medication.
Register today! We will email a reminder and webinar link shortly before the date of the webinar. Registration closes noon PST July 26, 2025. If you cannot attend but are interested in receiving notification of other PDC events, please complete this form.